Literature DB >> 11897781

Contribution of human mlh1 and pms2 ATPase activities to DNA mismatch repair.

Guy Tomer1, Andrew B Buermeyer, Megan M Nguyen, R Michael Liskay.   

Abstract

MutLalpha, a heterodimer composed of Mlh1 and Pms2, is the major MutL activity in mammalian DNA mismatch repair. Highly conserved motifs in the N termini of both subunits predict that the protein is an ATPase. To study the significance of these motifs to mismatch repair, we have expressed in insect cells wild type human MutLalpha and forms altered in conserved glutamic acid residues, predicted to catalyze ATP hydrolysis of Mlh1, Pms2, or both. Using an in vitro assay, we showed that MutLalpha proteins altered in either glutamic acid residue were each partially defective in mismatch repair, whereas the double mutant showed no detectable mismatch repair. Neither strand specificity nor directionality of repair was affected in the single mutant proteins. Limited proteolysis studies of MutLalpha demonstrated that both Mlh1 and Pms2 N-terminal domains undergo ATP-induced conformational changes, but the extent of the conformational change for Mlh1 was more apparent than for Pms2. Furthermore, Mlh1 was protected at lower ATP concentrations than Pms2, suggesting Mlh1 binds ATP with higher affinity. These findings imply that ATP hydrolysis is required for MutLalpha activity in mismatch repair and that this activity is associated with differential conformational changes in Mlh1 and Pms2.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897781     DOI: 10.1074/jbc.M111342200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Modulation of microRNA processing by mismatch repair protein MutLα.

Authors:  Guogen Mao; Sanghee Lee; Janice Ortega; Liya Gu; Guo-Min Li
Journal:  Cell Res       Date:  2012-01-31       Impact factor: 25.617

2.  ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts.

Authors:  Ken-ichi Yoshioka; Yoshiko Yoshioka; Peggy Hsieh
Journal:  Mol Cell       Date:  2006-05-19       Impact factor: 17.970

3.  Human PMS2 gene family: origin, molecular evolution, and biological implications.

Authors:  D G Shpakovskii; E K Shematorova; G V Shpakovskii
Journal:  Dokl Biochem Biophys       Date:  2006 May-Jun       Impact factor: 0.788

4.  Arsenic Inhibits DNA Mismatch Repair by Promoting EGFR Expression and PCNA Phosphorylation.

Authors:  Dan Tong; Janice Ortega; Christine Kim; Jian Huang; Liya Gu; Guo-Min Li
Journal:  J Biol Chem       Date:  2015-04-23       Impact factor: 5.157

5.  An intact Pms2 ATPase domain is not essential for male fertility.

Authors:  Jared M Fischer; Sandra Dudley; Ashleigh J Miller; R Michael Liskay
Journal:  DNA Repair (Amst)       Date:  2015-12-29

6.  Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links.

Authors:  Akshada Sawant; Anbarasi Kothandapani; Anatoly Zhitkovich; Robert W Sobol; Steve M Patrick
Journal:  DNA Repair (Amst)       Date:  2015-10-23

7.  The E705K mutation in hPMS2 exerts recessive, not dominant, effects on mismatch repair.

Authors:  Suzanne M Deschênes; Guy Tomer; Megan Nguyen; Naz Erdeniz; Nicole C Juba; Natalia Sepúlveda; Jenna E Pisani; R Michael Liskay
Journal:  Cancer Lett       Date:  2006-10-09       Impact factor: 8.679

8.  Direct visualization of asymmetric adenine-nucleotide-induced conformational changes in MutL alpha.

Authors:  Elizabeth J Sacho; Farid A Kadyrov; Paul Modrich; Thomas A Kunkel; Dorothy A Erie
Journal:  Mol Cell       Date:  2008-01-18       Impact factor: 17.970

9.  Human MutL homolog (MLH1) function in DNA mismatch repair: a prospective screen for missense mutations in the ATPase domain.

Authors:  Aaron R Ellison; Joan Lofing; Grant A Bitter
Journal:  Nucleic Acids Res       Date:  2004-10-08       Impact factor: 16.971

10.  Functions of MutLalpha, replication protein A (RPA), and HMGB1 in 5'-directed mismatch repair.

Authors:  Jochen Genschel; Paul Modrich
Journal:  J Biol Chem       Date:  2009-06-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.